相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthetic investigational new drugs for the treatment of tuberculosis
Yong-Soo Kwon et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy
Caroline M. Pule et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
Daniel T. Hoagland et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
Robert S. Wallis et al.
LANCET INFECTIOUS DISEASES (2016)
Catalytic asymmetric synthesis of CPZEN-45
Toshifumi Takeuchi et al.
TETRAHEDRON LETTERS (2016)
Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings
Derek J. Sloan et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2016)
Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones
Antonios Douros et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone
Pooja Gopal et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide
Juanjuan Yang et al.
MOLECULAR MICROBIOLOGY (2015)
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
Grania Brigden et al.
INFECTION AND DRUG RESISTANCE (2015)
In Vitro and In Vivo Activities of the Nitroimidazole TBA-354 against Mycobacterium tuberculosis
A. M. Upton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Verapamil Increases the Bactericidal Activity of Bedaquiline against Mycobacterium tuberculosis in a Mouse Model
Shashank Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review
Marva Seifert et al.
PLOS ONE (2015)
Newer patents in antimycobacterial therapy
S. K. Shahid
PHARMACEUTICAL PATENT ANALYST (2015)
Efflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosis
Shashank Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis
Monalisa Chatterji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Synthetic approaches to the 2012 new drugs
Hong X. Ding et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Determination of TBI-166, a Novel Antituberculotic, in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry
Dan Li et al.
CHROMATOGRAPHIA (2014)
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria
Galina Karabanovich et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Liquid chromatographic determination of CPZEN-45, a novel anti-tubercular drug, in biological samples
S. N. M. Hanif et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Synthesis and Biological Evaluation of Novel 2-Methoxypyridylamino-Substituted Riminophenazine Derivatives as Antituberculosis Agents
Dongfeng Zhang et al.
MOLECULES (2014)
Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux
Richard E. Lee et al.
NATURE MEDICINE (2014)
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
Wanliang Shi et al.
EMERGING MICROBES & INFECTIONS (2014)
Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis
Suhail Ahmad et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2014)
Molecular Basis of Drug Resistance in Mycobacterium tuberculosis
Keira A. Cohen et al.
MICROBIOLOGY SPECTRUM (2014)
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis
Giovanni Battista Migliori et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Resistance to fluoroquinolones and second-Line injectable drugs: impact on multidrug-resistant TB outcomes
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
para-Aminosalicylic Acid Is a Prodrug Targeting Dihydrofolate Reductase in Mycobacterium tuberculosis
Jun Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mutations in the embB Gene and Their Association with Ethambutol Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates from Poland
Zofia Bakula et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
Shuo Zhang et al.
EMERGING MICROBES & INFECTIONS (2013)
Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
A. H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Alena Skrahina et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Multidrug-resistant tuberculosis in Eastern Europe: still on the increase?
Giovanni Battista Migliori et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
National Survey of Drug-Resistant Tuberculosis in China
Yanlin Zhao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Thiostrepton inhibits stable 70S ribosome binding and ribosome-dependent GTPase activation of elongation factor G and elongation factor 4
Justin D. Walter et al.
NUCLEIC ACIDS RESEARCH (2012)
Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation
Yu Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Identification of SQ609 as a lead compound from a library of dipiperidines
Elena Bogatcheva et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis
Pedro Eduardo Almeida da Silva et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Wanliang Shi et al.
SCIENCE (2011)
Novel Mycobacterium tuberculosis Complex Pathogen, M. mungi
Kathleen A. Alexander et al.
EMERGING INFECTIOUS DISEASES (2010)
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
U. Mack et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
Emma C. Rivers et al.
DRUG DISCOVERY TODAY (2008)
Bacterial growth and cell division: a mycobacterial perspective
Erik C. Hett et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment
H. D. Hollis Showalter et al.
TUBERCULOSIS (2008)
In vitro antimycobacterial activities of capuramycin analogues
Venkata M. Reddy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice
Makoto Matsumoto et al.
PLOS MEDICINE (2006)
Multidrug-resistance efflux pumps - not just for resistance
Laura J. V. Piddock
NATURE REVIEWS MICROBIOLOGY (2006)
Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex
Richard C. Huard et al.
JOURNAL OF BACTERIOLOGY (2006)
Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines
M Protopopova et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Synthesis and SAR of novel oxazolidinones: Discovery of ranbezolid
B Das et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages
R Sood et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp.
M Igarashi et al.
JOURNAL OF ANTIBIOTICS (2005)
The structure of a mycobacterial outer-membrane channel
M Faller et al.
SCIENCE (2004)
The life and times of ivermectin - a success story
S Omura et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents
LM Ednie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid
Y Zhang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
A new evolutionary scenario for the Mycobacterium tuberculosis complex
R Brosch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II
H Marrakchi et al.
MICROBIOLOGY-UK (2000)
分享论文
